The Vice Presidents team at Outlook Therapeutics is responsible for high-level strategic oversight and decision-making across critical domains. This includes identifying and securing licensing opportunities and managing mergers and acquisitions (Senior Vice President, Licensing and Mergers & Acquisitions), overseeing clinical trials and ensuring regulatory compliance (Senior Vice President, Clinical & Regulatory Affairs), and guiding medical strategies and stakeholder engagement relating to ONS-5010 / LYTENAVA™ (Senior Vice President, Medical Affairs).
View all